Nafronyl oxalate
CAS No. 3200-06-4
Nafronyl oxalate( Nafronyl Oxalate | Dubimax: Dusodril: Naftidrofuryl oxalate )
Catalog No. M14041 CAS No. 3200-06-4
A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 30 | In Stock |
|
| 100MG | 42 | In Stock |
|
| 200MG | 61 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNafronyl oxalate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.
-
DescriptionA drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors. (In Vitro):Naftidrofuryl oxalate (Nafronyl oxalate salt) may be effective for relieving the pain of muscle cramps.Naftidrofuryl oxalate (Nafronyl oxalate salt) is the only vasoactive drug for peripheral arterial disease (PAD) which is likely to be cost-effective.Naftidrofuryl oxalate (Nafronyl oxalate salt) is ranked first for both maximum walking distance (MWD) and pain-free walking distance (PFWD) (probability of 0·947 and 0·987, respectively, of being the best treatment) followed by cilostazol and pentoxifylline. Naftidrofuryl oxalate (Nafronyl oxalate salt) is effective treatments for claudication, Naftidrofuryl oxalate is likely to be the most effective, with minimal serious adverse events.
-
In VitroNaftidrofuryl oxalate (Nafronyl oxalate salt) may be effective for relieving the pain of muscle cramps.Naftidrofuryl oxalate (Nafronyl oxalate salt) is the only vasoactive drug for peripheral arterial disease (PAD) which is likely to be cost-effective.Naftidrofuryl oxalate (Nafronyl oxalate salt) is ranked first for both maximum walking distance (MWD) and pain-free walking distance (PFWD) (probability of 0·947 and 0·987, respectively, of being the best treatment) followed by cilostazol and pentoxifylline. Naftidrofuryl oxalate (Nafronyl oxalate salt) is effective treatments for claudication, Naftidrofuryl oxalate is likely to be the most effective, with minimal serious adverse events.
-
In Vivo——
-
SynonymsNafronyl Oxalate | Dubimax: Dusodril: Naftidrofuryl oxalate
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number3200-06-4
-
Formula Weight473.56
-
Molecular FormulaC26H35NO7
-
Purity>98% (HPLC)
-
SolubilityWater: 10 mM
-
SMILESO=C(OCCN(CC)CC)C(CC1=C2C=CC=CC2=CC=C1)CC3OCCC3.O=C(O)C(O)=O
-
Chemical Name2-(Diethylamino)ethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate Oxalate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim MJ, et al. Clin Exp Nephrol. 2013 Jun;17(3):437-8.
molnova catalog
related products
-
MM 77 dihydrochlorid...
MM 77 dihydrochloride is an effecitve 5-HT1A receptor postsynaptic antagonist with anxiolytic-like activity.
-
SB 737050A
SB 737050A is a potent, selective 5-HT6 receptor antagonist to prevent relapse intio addiction.
-
F-15599
F-15599 is a highly selective G-protein biased 5-HT1A receptor agonist(Ki : 3.4 nM).
Cart
sales@molnova.com